Altered expression of inflammation-related genes in human carotid atherosclerotic plaques

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 93-101

  Di Taranto, Maria Donata ^a   Morgante, Alberto ^b,c   Bracale, Umberto Marcello ^c   D'Armiento, Francesco Paolo ^c   Porcellini, Massimo ^c   Bracale, Giancarlo ^c   Fortunato, Giuliana ^b,c   Salvatore, Francesco ^b  

^a IRCCS SDN   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Atherosclerosis; Eicosanoid pathway; Gene expression; Inflammation; Oxidative stress

Indexed keywords

ENZYME; ICOSANOID; MESSENGER RNA;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; MALE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; UPREGULATION;

AGED; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; ITALY; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, CYTOKINE; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84155164862     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.022     Document Type: Article

References (31)

1. Libby P., Ridker P.M., Hansson G.K. Leducq transatlantic network on atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
2. Fortunato G., Di Taranto M.D. Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases. Clin Chim Acta 2007, 381:21-25.
3. Galkina E., Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2292-2301.
4. Zhou Z., Connell M.C., MacEwan D.J. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 2007, 19:1238-1248.
5. Abraham S., Kogata N., Fässler R., Adams R.H. Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ Res 2008, 102:562-570.
6. Antoniades C., Bakogiannis C., Tousoulis D., Antonopoulos A.S., Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 2009, 54:669-677.
7. Bäck M., Ketelhuth D.F., Agewall S. Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis 2010, 52:410-428.
8. Riccioni G., Bäck M., Capra V. Leukotrienes and atherosclerosis. Curr Drug Targets 2010, 11:882-887.
9. Cipollone F., Cicolini G., Bucci M. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol Ther 2008, 118:161-180.
10. Qiu H., Gabrielsen A., Agardh H.E., et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA 2006, 103:8161-8166.
11. Zhou Y.J., Wang J.H., Li L., Yang H.W., Wen de L., He Q.C. Expanding expression of the 5-lipoxygenase/leukotriene B(4) pathway in atherosclerotic lesions of diabetic patients promotes plaque instability. Biochem Biophys Res Commun 2007, 363:30-36.
12. McGeer P.L., McGeer E.G., Yasojima K. Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaques. Exp Gerontol 2002, 37:925-929.
13. Biller J., Feinberg W.M., Castaldo J.E., et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1998, 97:501-509.
14. Fortunato G., Di Taranto M.D., Bracale U.M., et al. Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:594-600.
15. Raitoharju E., Lyytikäinen L.P., Levula M., et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the tampere vascular study. Atherosclerosis 2011, July 22 [Epub ahead of print].
16. Zawadzki C., Chatelain N., Delestre M., et al. Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis 2009, 204:e4-e14.
17. Mälarstig A., Sigurdsson S., Eriksson P., et al. Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction. Arterioscler Thromb Vasc Biol 2008, 28:975-982.
18. Stary H.C., Chandler A.B., Glagov S., et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Special report. Arterioscler Thromb 1994, 14:840-856.
19. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995, 15:1512-1531.
20. Sumagin R., Prizant H., Lomakina E., Waugh R.E., Sarelius I.H. LFA-1 and Mac-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ. J Immunol 2010, 185:7057-7066.
21. Rochman Y., Spolski R., Leonard W.J. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 2009, 9:480-490.
22. Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008, 79:360-376.
23. Banfi C., Colli S., Eligini S., Mussoni L., Tremoli E. Oxidized LDLs influence thrombotic response and cyclooxygenase 2. Prostaglandins Leukot Essent Fatty Acids 2002, 67:169-173.
24. Li R., Mouillesseaux K.P., Montoya D., et al. Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ Res 2006, 98:642-650.
25. Cipollone F., Fazia M.L., Iezzi A., et al. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol 2005, 25:1925-1931.
26. Tanaka R., Miwa Y., Mou K., et al. Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice. Biochem Biophys Res Commun 2009, 378:851-856.
27. Yu Y., Lucitt M.B., Stubbe J., et al. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci USA 2009, 106:7985-7990.
28. Vila L. Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med Res Rev 2004, 24:399-424.
29. Vane J., Corin R.E. Prostacyclin: a vascular mediator. Eur J Vasc Endovasc Surg 2003, 26:571-578.
30. Cyrus T., Ding T., Praticò D. Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque composition. Atherosclerosis 2010, 208:376-381.
31. Itoh A., Nishihira J., Makita H., Miyamoto K., Yamaguchi E., Nishimura M. Effects of IL-1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells. Respirology 2003, 8:467-472.